International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Pharmaceutical Diplomacy in Asia: A Regional Architecture for Health Security, Innovation, and Strategic Autonomy
| Author(s) | Ms. Shefali Patnaik, Dr. Sibaram Badatya, Dr. Mahendra Pratap Swain |
|---|---|
| Country | India |
| Abstract | The concept of pharmaceutical diplomacy has a vital role to play in the realm of international relations and geopolitics as a channel between the negotiation of economic relations with regard to health security and soft power. Asia has proved that it can compete in the pharmaceutical level, with China and India together providing a substantial percentage of the overall API manufacturing at a global level, and other states with their comparative advantages further enriching the pharmaceutical picture in Asia. This development has changed Asia into a powerhouse on the global level. Nevertheless, despite such existing tangible upsides, Asian representativeness in the design of global health policy has been limited. The region's ability to act as normative authority in international health was hindered by intra and inter-state regulatory conflicts, compounded by the state. Taking a comparative approach and using qualitative case study methodology, this paper explores the patchy nature of the multisided pharmaceutical capabilities of Asian states. Through the present analysis the paper intends to establish a realistic objective of the united Asian Pharmaceutical Alliance, in conjunction with the Asian Medicines and Health Security Authority (AMSHA) sourced from a super-continental concept. This initiative would ensure the API supply chains and maintain stability by strengthening the collective bargaining power of the continent in the global health sector. Moreover, the study shows that it is critical that pharmaceutical technology is integrated into the regional collaboration framework as an integral part of the expectation of Asia’s move towards a leading pharmaceutical destination, in line with the growth within the framework of systematic development. This evolution path may place the region in a favorable pharmaceutical space for global health security, paving the way for its survival and maintenance of its strategic autonomy in the international circles and by reducing dependence on Western powers. |
| Keywords | Pharmaceutical Diplomacy, Asian Pharmaceutical Alliance, Soft Power, Health Security, Pharma 4.0, Proposal of AMHSA, Regulatory Harmonization |
| Field | Sociology > Politics |
| Published In | Volume 7, Issue 5, September-October 2025 |
| Published On | 2025-10-31 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i05.59070 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals